Table 1.
Characteristic | Total (n = 261) |
---|---|
Age | |
Median (range) | 64 (27–88) |
Age > 60, n (%) | 157 (60) |
Sex, n (%) | |
Female | 161 (62) |
Male | 100 (38) |
ECOG score | |
0–1 | 148 (57) |
2–3 | 113 (43) |
Extranodal site, n (%) | |
Yes | 160 (61) |
No | 101 (39) |
Bulky disease, n (%) (≥ 10 cm) | |
Yes | 24 (9) |
No | 237 (91) |
Stage, n (%) | |
I | 36 (14) |
II | 57 (22) |
III | 75 (29) |
IV | 93 (34) |
Elevated LDH, n (%) | |
Yes | 124 (48) |
No | 137 (42) |
Bone marrow involvement | |
Yes | 33 (13) |
No | 228 (87) |
IPI score | |
0–2 | 132 (51) |
3–5 | 129 (49) |
Subtype n (%) | |
GCB | 78 (30) |
Non-GCB | 183 (70) |
NKCC4, n (%) | |
> 135 cell/μl | 111 (43) |
< 135 cell/μl | 150 (57) |
ECOG Eastern Cooperative Oncology Group; LDH serum lactate dehydrogenase; IPI International Prognostic Index; GCB germinal center B cell-like; NKCC4 absolute peripheral blood NK cell count after four cycles of R-CHOP